Anticoagulant Reversal in Stroke:
Best Practices for Successful Outcomes

Registration and Dinner: 6:30PM - 7:00PM CT
Symposium: 7:00PM - 8:30PM CT

Venue: Omni Dallas Hotel
Ballroom: Dallas A
555 S Lamar St. Dallas, Texas


Chair: Truman Milling, Jr., MD

Faculty: Joshua N. Goldstein, MD; William F. Peacock, MD

Registration for this program is now closed.

There is a need for clinician awareness of the importance of anticoagulant reversal therapies and situations that warrant the administration of such therapies. Stroke specialists must be able to identify appropriate candidates for anticoagulant reversal in persons suffering an ischemic or hemorrhagic stroke, as well as how to select the most appropriate reversal therapy on an individualized patient basis. In particular, clinicians must have a greater recognition of the risks and potential consequences of anticoagulant reversal in patients receiving anticoagulant therapies and the treatment algorithms for initiating reversal therapy in the diverse and expanding patient populations who use anticoagulants. The growing reliance on non-vitamin K direct oral anticoagulants (DOACs) instead of traditional oral vitamin K anticoagulants (VKAs) necessitates knowledge regarding DOAC-specific reversal agents, including their benefits, risks, timing, dosing, and appropriate indications in order to optimize outcomes.

Educational Objectives: 

1. Discuss the current treatment algorithms for best practices regarding anticoagulant reversal therapies in patients with ischemic stroke or intracerebral hemorrhage
2. Assess efficacy, safety, timing and roles for traditional and new reversal agents for stroke patients on DOACs and warfarin
3. Describe the clinical evidence for restarting anticoagulant therapy after anticoagulation reversal in patients who have experienced major hemorrhage

Accreditation & Credit Designation:
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits^TM through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits ^TM from organizations accredited by the ACCME.

Educational Grant: Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Target Audience:  This educational activity is intended for clinicians managing patients experiencing a stroke.